Tuesday, October 31, 2017 - 4:26pm
Prevention & Screening
Advancements in technology have improved screening quality while decreasing the need for additional images. In 2011, the Food and Drug Administration approved the use of tomosynthesis or 3D screening mammography. Since then, multiple studies have found that 3D screenings have reduced the need to recall patients for additional images up to 17 percent.